Teriflunomide

FDA Approved: * July 27, 2018
Pharm Company: * WATSON LABS TEVA
Category: Multiple Sclerosis

Teriflunomide, sold under the brand name Aubagio, is the active metabolite of leflunomide.[2] Teriflunomide was investigated in the Phase III clinical trial TEMSO as a medication for multiple sclerosis (MS). The study was completed in July 2010.[3] 2-year results were positive.[4] However, the subsequent TENERE head-to-head comparison trial reported that "although permanent discontinuations [of therapy] were substantially less common among M... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Teriflunomide 14 mg Oral Tablet, Film Coated
NDC: 0115-1565
Labeler:
Amneal Pharmaceuticals of New York LLC
Teriflunomide 7 mg Oral Tablet, Film Coated
NDC: 68462-311
Labeler:
Glenmark Pharmaceuticals Inc., USA
Teriflunomide 14 mg Oral Tablet, Film Coated
NDC: 68462-312
Labeler:
Glenmark Pharmaceuticals Inc., USA
Teriflunomide 7 mg Oral Tablet, Film Coated
NDC: 69238-1303
Labeler:
Amneal Pharmaceuticals LLC
Teriflunomide 14 mg Oral Tablet, Film Coated
NDC: 69238-1304
Labeler:
Amneal Pharmaceuticals LLC
Teriflunomide 7 mg Oral Tablet, Film Coated
NDC: 69539-032
Labeler:
Msn Laboratories Private Limited
Teriflunomide 14 mg Oral Tablet, Film Coated
NDC: 69539-033
Labeler:
Msn Laboratories Private Limited

Related Brands

Drugs with the same active ingredients